Certified by Founder Lodge
Sable Bio
United Kingdom - London
START UP
1 Disclosed Funding Rounds $1,883,707
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Prevent target safety failures with unique data insights and cutting-edge approaches.
Better prediction of drug safety could help patients and prevent hugely costly trial failures. Our ad
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 06 ,2024 | Pre-Seed | $1,883,707 |
Episode 1 Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Manufact (formerly mcp-use) | $6,300,000 | (Feb 13, 2026)
CYDELPHI | $3,000,000 | (Feb 13, 2026)
Integrate | $17,000,000 | (Feb 13, 2026)
Maestro Tech, Inc. | $1,200,000 | (Feb 13, 2026)
Reflow | $15,000,000 | (Feb 13, 2026)
